Driving Manufacturing Process Innovation for Engineering and Expansion of Tumor-Infiltrating Lymphocytes

Time: 10:00 am
day: Day Two


• Discussing the current state of TIL manufacturing processes and need for innovation
• Optimizing viral vector engineering of TILs for transgene expression
• Implementing novel feeders to support robust expansion of engineered TILs
• Innovating continuously for reduced COGS, close processing and automation